Position in TRDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,902,216
+$188,690 QoQ
Shares Held
394,323
+83.4% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 128 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Derivatives in TRDA
reported options exposure · as of Mar 31, 2025CallValue
$74,128
CallShares
8,200
PutValue
$20,792
PutShares
2,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,855,369 across 436 Biotechnology names. TRDA ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in TRDA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,902,216 | 394,323 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,713,526 | 215,018 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,009,674 | 292,770 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,947,297 | 335,741 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $674,398 | 100,357 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $74,128 | 8,200 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $148,735 | 16,453 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $20,792 | 2,300 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $148,694 | 8,600 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,221,866 | 70,669 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $70,889 | 4,100 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $76,704 | 4,800 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $81,498 | 5,100 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $1,409,818 | 88,224 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,425 | 100 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $1,858,898 | 130,449 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $987,308 | 69,676 | Shares | Defined | 2024-05-15 | |
| 2022-06-30 | $157,694 | 12,947 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $604,706 | 64,399 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,862,553 | 108,794 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||